SCN and Mitacs developed a partnership through the Mitacs Accelerate program, which will support the brightest graduate students and postdoctoral fellows conducting research in regenerative medicine. These interns will share their time (eight months) between academic institutions and companies, to power life-saving therapies and technologies through regenerative medicine research for the benefit of all. This application cycle is for the Summer/Fall 2025 term (for projects beginning no earlier than August 2025) and will fund up to five intern positions.
Partner Companies (See here for a full internship description):
- Axolotl Biosciences
- Epiloid Biotechnology
- Feldan Therapeutics
- Mediphage Bioceuticals
- Mesintel Therapeutics
- Octane Orthobiologics
- Telescope Therapeutics
- Virano Therapeutics
Further Information
Application Procedures
Please refer to the Stemcell website for application procedures.
Eligibility Requirements
Please refer to the Stemcell website for eligibility requirements.
Evaluation Criteria
Please refer to the Stemcell website for evaluation criteria.